TIAA CREF Investment Management’s Asensus Surgical, Inc. ASXC Stock Holding History

TIAA CREF Investment Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.26M	Buy	40,782 +16,498	+68%	+$553K	﹤0.01%	2217
2018 Q4	$713K	Sell	24,284 -143	-0.6%	-$6.5K	﹤0.01%	2420
2018 Q3	$1.84M	Sell	24,427 -1,896	-7%	-$128K	﹤0.01%	2164
2018 Q2	$1.49M	Buy	+26,323	New	+$959K	﹤0.01%	2315
2017 Q2	–	Sell	-14,695	Closed	-$231K	–	3188
2017 Q1	$231K	Sell	14,695 -546	-4%	-$9.46K	﹤0.01%	2967
2016 Q4	$258K	Buy	15,241 +455	+3%	+$9.33K	﹤0.01%	3004
2016 Q3	$325	Buy	14,786 +805	+6%	+$14.7K	﹤0.01%	2982
2016 Q2	$222K	Buy	13,981 +4,001	+40%	+$126K	﹤0.01%	3079
2016 Q1	$551K	Sell	9,980 -1,024	-9%	-$43.9K	﹤0.01%	2757
2015 Q4	$355K	Hold	11,004	–	–	﹤0.01%	2983
2015 Q3	$323K	Sell	11,004 -7,694	-41%	-$285K	﹤0.01%	2986
2015 Q2	$729K	Buy	18,698 +6,456	+53%	+$297K	﹤0.01%	2845
2015 Q1	$466K	Buy	12,242 +2,858	+30%	+$108K	﹤0.01%	2938
2014 Q4	$355K	Buy	9,384 +187	+2%	+$7.72K	﹤0.01%	3033
2014 Q3	$521K	Sell	9,197 -1,770	-16%	-$95.4K	﹤0.01%	2959
2014 Q2	$719K	Buy	+10,967	New	+$633K	﹤0.01%	2905

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's ASXC Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Asensus Surgical, Inc. (ASXC) stake by 68% in Q1 2019, buying an estimated $553K and bringing the position to 40,782 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

TIAA CREF Investment Management first reported a position in ASXC in Q2 2014 and has held it in 16 quarters since. The position peaked at $1.84M in Q3 2018. 149 funds tracked by Wall St. Rank hold ASXC as of Q1 2019.

TIAA CREF Investment Management held 40,782 shares of Asensus Surgical, Inc. worth $1.26M as of Q1 2019.
TIAA CREF Investment Management bought 16,498 Asensus Surgical, Inc. shares in Q1 2019, an estimated $553K.
Asensus Surgical, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2217 holding.
TIAA CREF Investment Management first reported a position in Asensus Surgical, Inc. in Q2 2014 and has held it in 16 quarters since.
TIAA CREF Investment Management's Asensus Surgical, Inc. position peaked at $1.84M in Q3 2018.
149 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.